Drug delivery using platelet cancer cell interaction
- PMID: 23739991
- DOI: 10.1007/s11095-013-1097-1
Drug delivery using platelet cancer cell interaction
Abstract
Purpose: To develop an efficient biocompatible and _targeted drug delivery system in which platelets, an essential blood component having a natural affinity for cancer cells, are used as carrier of anticancer drug as delivery of drug to the _targeted site is crucial for cancer treatment.
Methods: Doxorubicin hydrochloride, a potent anti cancer drug, was delivered in lung adenocarcinoma cell line (A549) using platelet as a delivery agent. This delivery mode was also tested in Ehrlich ascites carcinoma (EAC) bearing mice in presence and absence of platelets.
Results: The results show that platelets can uptake the drug and release the same upon activation. The efficiency of drug loaded platelets in inducing cytotoxicity was significantly higher in both in vitro and in vivo model, as compared to the free drug.
Conclusions: The proposed drug delivery strategy may lead to clinical improvement in the management of cancer treatment as lower drug concentration can be used in a _targeted mode. Additionally the method can be personalized as patient's own platelet can be used for deliver various drugs.
Similar articles
-
Multistimuli-Responsive Bilirubin Nanoparticles for Anticancer Therapy.Angew Chem Int Ed Engl. 2016 Aug 26;55(36):10676-80. doi: 10.1002/anie.201604858. Epub 2016 Aug 3. Angew Chem Int Ed Engl. 2016. PMID: 27485478
-
Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.Drug Des Devel Ther. 2019 Apr 5;13:1087-1098. doi: 10.2147/DDDT.S198003. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31118562 Free PMC article.
-
Heparan sulfate _targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors.Drug Deliv. 2020 Dec;27(1):542-555. doi: 10.1080/10717544.2020.1745326. Drug Deliv. 2020. PMID: 32241176 Free PMC article.
-
Platelets for advanced drug delivery in cancer.Expert Opin Drug Deliv. 2023 May;20(5):673-688. doi: 10.1080/17425247.2023.2217378. Epub 2023 May 26. Expert Opin Drug Deliv. 2023. PMID: 37212640 Review.
-
Platelet cancer cell interplay as a new therapeutic _target.Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188770. doi: 10.1016/j.bbcan.2022.188770. Epub 2022 Aug 1. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35926688 Review.
Cited by
-
The impact of platelets on the metastatic potential of tumour cells.Heliyon. 2024 Jul 14;10(14):e34361. doi: 10.1016/j.heliyon.2024.e34361. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39114075 Free PMC article. Review.
-
Combination of drugs and carriers in drug delivery technology and its development.Drug Des Devel Ther. 2019 Apr 30;13:1401-1408. doi: 10.2147/DDDT.S198056. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31118575 Free PMC article. Review.
-
Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application.Transfus Med Hemother. 2017 Jun;44(3):165-173. doi: 10.1159/000477261. Epub 2017 May 23. Transfus Med Hemother. 2017. PMID: 28626367 Free PMC article. Review.
-
Platelets and their biomimetics for regenerative medicine and cancer therapies.J Mater Chem B. 2018 Dec 7;6(45):7354-7365. doi: 10.1039/C8TB02301H. Epub 2018 Oct 22. J Mater Chem B. 2018. PMID: 31372220 Free PMC article. Review.
-
Human induced pluripotent stem cell-derived platelets loaded with lapatinib effectively _target HER2+ breast cancer metastasis to the brain.Sci Rep. 2021 Oct 15;11(1):16866. doi: 10.1038/s41598-021-96351-2. Sci Rep. 2021. Retraction in: Sci Rep. 2024 Mar 12;14(1):5972. doi: 10.1038/s41598-024-56291-z PMID: 34654856 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical